The World’s $11.85 Trillion Healthcare Industry Has Yet To See an AI Platform As Transformative As Treatment.com’s

SPONSORED

The World’s $11.85 Trillion Healthcare Industry(1) Has Yet To See an AI Platform As Transformative As Treatment.com’s

The Top 3 Reasons Treatment.com Canada CSE: (TRUE) U.S. OTC: (TREIF) Could Revolutionize Healthcare

  1. Expert Team – Treatment.com Canada CSE: (TRUE) U.S. OTC: (TREIF) is led by a team of seasoned experts, top medical technology experts and doctors, and innovative business leaders who have developed and sold billion-dollar global healthcare businesses.(1)
  2. Industry Validation – Treatment.com’s Canada CSE: (TRUE) U.S. OTC: (TREIF) AI platform “Cara” has gone through years of studying and testing to “think like a doctor.” It has been validated by the University of Minnesota Medical School, a Top 10 global medical school.(1) It has been tested by a worldwide team of doctors, used to train medical students. It is also currently being rolled out nationally in Canada.
  3. Proprietary AI – Cara’s exclusive AI technology is one-of-a-kind and uniquely Treatment.com’s Canada CSE: (TRUE). The barriers to developing anything competitive are incredibly high.

Global healthcare is an $11.85 trillion behemoth.(1) The U.S. healthcare system alone could also be worth over half a trillion dollars by 2025.(1)

According to Forbes, healthcare may be the largest and most important sector in the U.S. economy. Close to $4 trillion per year is spent on healthcare in the United States.(2) It employs more people than any other industry, accounting for 11% of all American jobs. Nearly one-quarter of all U.S. government spending is dedicated to healthcare, too.(2)

So then, how in the heck does the U.S. rank 38th in the world when it comes to life expectancy?(2) Is this so-called superpower’s healthcare system really only good enough to have its life expectancy sandwiched between Lebanon and Cuba?(2)

Lebanon and Cuba are both failed states on the verge of collapse, for crying out loud.

Here’s what makes it look even more disastrous. U.S. healthcare costs have surged from $355 per person in 1970 to $11,172 per person as of 2018.(2) Access to healthcare also remains worse in the U.S. than in any other developed country.(2)

Despite demand screaming U.S. healthcare to become more technologically advanced, this is lagging, outdated, and behind-the-times, too.

According to PCMag, for instance, 83% of American healthcare systems are running outdated software. 56%, aka the majority, are running Windows 7. Microsoft officially stopped supporting Windows 7 in January 2020!(3)

This is catastrophic and inexcusable. ​​The U.S. digital health market is expected to achieve a 27.7% CAGR by 2025, while health AI is growing at a rate of 40%.(1) Consumer drive for personalized, digital information is also proliferating, with providers like WebMD reaching 80 million unique users per month.(1)

The bottom line is healthcare is overwhelming, expensive, and confusing, and consumers demand improved digital technology to manage their health.

“We’ve seen a huge demand in consumers wanting to take charge of their health. Consumers have been empowered by technology, they’re accessing more information than ever before,” said Scott Melville, CEO of the Consumer Healthcare Products Association.(1)

Fortunately, there’s a revolutionary company that realizes what an unmet need this is and how AI could transform medicine in ways we could’ve never dreamed up a decade ago.

Treatment.com Canada CSE: (TRUE) U.S. OTC: (TREIF) and its nex-gen Cara platform, could possess the most advanced and transformative healthcare AI service that the world has ever seen.

It’s taken years of research and development. Now, in the year 2021, it looks nothing short of groundbreaking and transformational. Treatment.com and Cara could genuinely go places where no other healthcare platform has gone before as a cutting-edge powerful AI service developed by doctors to “think like a doctor.”

All while putting the power back into people’s hands.

Who Exactly is Treatment.com Canada CSE: (TRUE) U.S. OTC: (TREIF)?

When you talk about Treatment.com Canada CSE: (TRUE) U.S. OTC: (TREIF), there are three significant points that sum up who they are and what they offer:

  • AI developed by the world’s leading doctors.
  • The mission to empower people with better information to make better health decisions.
  • A robust healthcare AI platform with many applications, including innovative medical research, doctor visits, improved insurance patient outcomes, and health trends towards prevention.

Treatment.com is a mission-driven company focused on providing better health for everyone and providing access to high-quality health information. It offers personalized health care information services and is best known for its Cara product, a personal AI-driven health assistant. Led by a global team of doctors, this company has come together to build one of the most powerful AI systems in the world.

For 5 years, Treatment.com’s global team of doctors and engineers trained the Treatment AI to think like a doctor. It was so effective that the University of Minnesota, a Top 10 international medical school,(1) licensed it to test medical students.

Today, this AI system has become the most personalized, intelligent healthcare AI. It is nothing short of supportive and caring, dynamic and scalable.(1)

The $11.85 trillion global healthcare system may never be the same, thanks to Treatment.com. The team at Treatment.com has taken a patient and consumer-centered approach to managing health. Throughout years of doing consumer testing and research, they figured out some of the most significant pain points for patients. Pain points including the influx of info, the overwhelming, expensive, and inaccessible system, and how it’s impossible to feel in total control of your health.

With accessible and supportive digital tools backed by powerful AI technology, Treatment.com is supporting caregivers and life changes to stay on top of their health and the health of their families.

Introducing Treatment.com’s Canada CSE: (TRUE) U.S. OTC: (TREIF) Cara Platform

Cara is Treatment.com’s baby. This AI health assistant has been developed to think and act like an actual doctor. After all, it did go through years of testing and training at medical school (the world-renowned University of Minnesota), like a real doctor would.(1)

“Our AI is so accurate that a top medical school is using it to test and train future doctors,” said the company.(1)

Cara, which can also be fully integrated with Apple Watch and Fitbit, can help users understand their condition and what to do next.(1)

This is not to say that it can or will fully replace actual doctors. On the contrary, actually. By taking some of the most common medical problems and using AI in the background, Cara can walk consumers through a series of assessments and instructions. It then can provide more beneficial info to act on symptoms.

In other words? This is a revolutionary supplementary service that can provide the following potential benefits:(1)

  • Understand what your symptom could be
  • Monitor and track health changes
  • Understand your general health and prevent illness
  • Receive personalized support and follow up
  • Track and manage your whole family


This infrastructure provides hyper-personalized health recommendations and better health info for people to make better health decisions. Cara by Treatment.com can create a global computing system of generalized health info that thinks the way a doctor thinks.

The Cara Difference

Cara creates a caring, long-lasting relationship with the customer and provides personalized recommendations that optimize their health over time.

This is done by having:(1)

  • Better Insights
  • Credibility
  • Increased Personalization
  • Caring Data
  • Simplicity and Approachableness
  • Comprehensive Support

The Business Model

Treatment.com plans to acquire Cara customers through digital advertising, social media, and the company website.(1)

It also has a triangular business model based on Mobile App Subscriptions, Health & Wellness E-Commerce, and Health Data Partnerships.(1)

Protected IP(1)

Cara is the product of years of technological innovation, relationships, knowledge acquisition, and business development. These key ingredients can’t be easily replicated and are protected by intellectual property laws and trade secrets.

  • Proprietary Models

Treatment.com’s Cara has a complex AI reasoning model designed to “think like a doctor.” It consists of numerous algorithms and complex probability inventions.

  • Specialized Teams

Over 5 years of intensive collaboration with a world-class team of doctors, engineers, mathematicians, and AI specialists.

  • Medical School Collaboration

To think like a doctor required Treatment.com to understand the way doctors are. The company sent its AI engine to a top 10 medical school (University of Minnesota).

  • Global Scalability

Treatment.com’s superior platform attracts experts worldwide to scale its medical knowledge base and expand its AI knowledge.

Treatment.com Canada CSE: (TRUE) U.S. OTC: (TREIF)– Newly Public With Limitless Potential

The TRUE stock has not been public for very long, and appears to have only been actively trading since April 19, 2021.(1)

There are several things to consider, though, when realizing the type of enormous opportunity at hand.

First and foremost, it’s a stock that has considerable pop potential. For instance, in the first month it traded, it rallied approximately 215% from its opening price of $2.00 to its May 20, 2021 peak of $6.30.(4)

Although the stock has pulled back, with a September 3, 2021 closing price of about $2.09 a share, check this out. Between 10:00AM EDT September 1, 2021, and the market open on September 3, 2021, the stock moved an astounding 21.05% from $1.90 to $2.30.(4)

It’s tough to believe that the stock is trading at this level. With a float of roughly 45.71M as of September 3, 2021,(5) a tight share structure with 41% insider ownership, and a cash position of $4,244,544 according to the company’s latest investor deck,(1) this company could be one of the most undervalued, potential high-growth plays in all of healthcare.

There’s never been an AI-driven platform quite like this before. Sure, you could compare it to outlets like K Health and WebMD. K Health offers a mobile app that enables users to check their symptoms, explore conditions and treatments, and chat with a doctor. At the same time, WebMD is known primarily as an online publisher of news and information about human health and well-being.(1) K Health and WebMD, as of May 1, 2021, also had approximate valuations of $458 million and $2.8 billion, respectively.(1)

Then there’s Babylon Health, ​​a health service provider that provides remote consultations with doctors and health care professionals via text and video messaging through its mobile application. It also agreed to go public in the United States through a SPAC led by former Groupon chief Rich Williams at a Pro-forma equity valuation of $4.2 billion in June 2021.(5)

Treatment.com, and its Cara platform, look like these services but on steroids. It has the potential to do so much more while being potentially undervalued with more generational promise.

Consider some of these competitive advantages that could also give Treatment.com and its Cara platform a dramatic edge over any other venues in the space:(1)

1) Personalized

Tailored assessments and recommendations from personal medical history, wearable data, and individual tracking data.

2) Supportive

AI that follow-ups like a doctor. Integration of intelligent tracking and monitoring into one app to support health and illness prevention.

3) Trustworthy

Treatment.com’s AI is trained by a global team of experts to continually learn, so it has the most accurate health data on the market.

Treatment.com Canada CSE: (TRUE) U.S. OTC: (TREIF)– The Leadership Is Its Secret Weapon

To train an AI system to actually think like a doctor takes an expert team with technological knowledge and real-world medical knowledge not only in the field, but also in the academic setting. This is a generationally transformative type of product that does not come around often. It takes a special kind of team with one-of-a-kind skill sets to turn it into a reality.

Learning more about the team behind this company makes it seem all the more enthralling.

Founding Team

John Fraser
CEO | PRESIDENT

John Fraser is a software and technology expert who has built and sold several healthcare software companies. His first company, Ability Networks, was recently purchased by Innovalon for $1.2B.

Dr. Kevin Peterson MD, MPH, FRCS(ED), FAAFP
CHAIRMAN & CHIEF MEDICAL OFFICER

Kevin Peterson focuses on chronic disease management, health services, diabetes, bioinformatics, and clinical trials in primary care. He has been the Principal Investigator (PI) or site-PI on many National Institutes of Health-funded studies and created a national electronic primary care research infrastructure.

Dr. Rob Scott MD CCFP
CHIEF INNOVATION OFFICER

Founder of Remedy, an allied healthcare professional online consulting company, Rob is an Assistant Clinical Professor in the Department of Family Practice at the University of British Columbia. He has been doing informatics research for over 20 years, specializing in patient self-care, developing technologies that support patient empowerment.

Business Team

Samantha Rayner
VP MARKETING

Samantha has worked in the consumer marketing industry for over 15 years, leading brand strategies for world-class global wellness companies, including Lululemon and Saje Natural Wellness. She has expertise in building purpose-lead brands and executing marketing campaigns that drive awareness, build communities, and generate sales.

AI Informatics Team

Dr. Ray Artz
STATISTICIAN & DATA SCIENTIST

Dr. Artz has advanced degrees in Mathematics and Statistics and 30 years of experience in the Defense Industry. He has served as a System Analyst, Computer System Architect, and Software Developer for numerous development projects, including the NEXRAD Doppler Weather Radar System and the F-35 Lightning II Joint Strike Fighter. He has also been a member of the Technical Advisory Committee for the DoD-sponsored High-Performance Embedded Computing (HPEC) conferences held annually at MIT Lincoln Laboratories.

Dr. David Poole
DIRECTOR MACHINE LEARNING RESEARCH

David Poole is a Professor of Computer Science at the University of British Columbia. He is known for his work combining logic and probability, assumption-based reasoning, diagnosis, relational probabilistic models, algorithms for probabilistic inference, representations and algorithms for automated decision making, probabilistic reasoning with ontologies, and semantic science. He is the chair of the Association for Uncertainty in Artificial Intelligence, a Fellow of the Association for the Advancement Artificial Intelligence (AAAI), and the winner of the Canadian AI Association (CAIAC) 2013 Lifetime Achievement Award.

Dr. Martin Michalowski
AI AND HEALTH INFORMATICS

Martin is a leading expert in automated reasoning. His work improves patient outcomes by applying logic-based approaches to reconcile clinical practice guidelines for multi-morbid patients. He is the co-founder of two technology-based companies and the technical lead of another. He is the organizing chair of the Expanding the Boundaries of Health Informatics using Artificial Intelligence (HIAI) workshop held at the Association for the Advancement of Artificial Intelligence (AAAI) conference.

The Top 3 Reasons Treatment.com Canada CSE: (TRUE) U.S. OTC: (TREIF) Could Revolutionize Healthcare

  1. Expert Team – Treatment.com Canada CSE: (TRUE) U.S. OTC: (TREIF) is led by a team of seasoned experts, top medical technology experts and doctors, and innovative business leaders who have developed and sold billion-dollar global healthcare businesses.(1)
  2. Industry Validation – Treatment.com’s Canada CSE: (TRUE) U.S. OTC: (TREIF) AI platform “Cara” has gone through years of studying and testing to “think like a doctor.” It has been validated by the University of Minnesota Medical School, a Top 10 global medical school.(1) It has been tested by a worldwide team of doctors, used to train medical students. It is also currently being rolled out nationally in Canada.
  3. Proprietary AI – Cara’s exclusive AI technology is one-of-a-kind and uniquely Treatment.com’s Canada CSE: (TRUE) U.S. OTC: (TREIF). The barriers to developing anything competitive are incredibly high.

 

Source 1: Client Provided Investor Deck
Source 2: https://www.forbes.com/sites/robtoews/2020/08/26/ai-will-revolutionize-healthcare-the-transformation-has-already-begun/?sh=3b044201722f
Source 3: https://bit.ly/3hsfXhd
Source 4: https://www.barchart.com/stocks/quotes/TRUE.CN/interactive-chart
Source 5: https://www.reuters.com/technology/online-health-startup-babylon-go-public-via-42-bln-spac-deal-2021-06-03/